BTK inhibitors: toxicity, resistance, and combinations - 101793

Spotlight
Video

BTK inhibitors: toxicity, resistance, and combinations

VJHemOnc has 1541 videos Subscribe Here

Loading........
Description: Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses recent developments in BTK inhibitors at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. BTK inhibitors have been shown to be effective in CLL, mantle cell lymphoma, Waldenstrom macroglobulinemia, and MALT lymphomas, and are constantly being developed to reduce toxicity. More is also being learned about their resistance mechanisms, and the benefit of combinations.
Shared By : VJHemOnc
Posted on : 11/21/17
Added : 10 months ago